Progyny (PGNY) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Progyny Revenue Highlights


Latest Revenue (Y)

$1.09B

Latest Revenue (Q)

$304.09M

Main Segment (Y)

Fertility benefit services revenue

Progyny Revenue by Period


Progyny Revenue by Year

DateRevenueChange
2023-12-31$1.09B38.34%
2022-12-31$786.91M57.19%
2021-12-31$500.62M45.17%
2020-12-31$344.86M50.15%
2019-12-31$229.68M117.92%
2018-12-31$105.40M116.94%
2017-12-31$48.58M-

Progyny generated $1.09B in revenue during NA 2023, up 38.34% compared to the previous quarter, and up 1032.83% compared to the same period a year ago.

Progyny Revenue by Quarter

DateRevenueChange
2024-06-30$304.09M9.35%
2024-03-31$278.08M3.01%
2023-12-31$269.94M-3.90%
2023-09-30$280.89M0.54%
2023-06-30$279.37M8.12%
2023-03-31$258.39M20.56%
2022-12-31$214.32M4.36%
2022-09-30$205.37M5.32%
2022-06-30$195.00M13.23%
2022-03-31$172.22M35.02%
2021-12-31$127.55M4.31%
2021-09-30$122.28M-4.95%
2021-06-30$128.65M5.34%
2021-03-31$122.13M21.77%
2020-12-31$100.30M1.39%
2020-09-30$98.93M53.13%
2020-06-30$64.61M-20.26%
2020-03-31$81.02M24.42%
2019-12-31$65.12M6.42%
2019-09-30$61.20M8.95%
2019-06-30$56.17M19.01%
2019-03-31$47.20M61.71%
2018-12-31$29.19M5.00%
2018-09-30$27.80M6.27%
2018-06-30$26.16M17.52%
2018-03-31$22.26M-

Progyny generated $304.09M in revenue during Q2 2024, up 9.35% compared to the previous quarter, and up 117.68% compared to the same period a year ago.

Progyny Revenue Breakdown


Progyny Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Fertility benefit services revenue$676.29M$510.14M$355.62M--
Pharmacy benefit services revenue$412.30M$276.77M$145.00M--
Fertility Benefit Services---$253.56M$189.62M
Pharmacy Benefit Services---$91.30M$40.06M

Progyny's latest annual revenue breakdown by segment (product or service), as of Dec 23: Fertility benefit services revenue (62.13%), and Pharmacy benefit services revenue (37.87%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Pharmacy benefit services revenue$108.31M$98.64M$105.78M$106.64M$101.25M$76.07M$68.21M$61.30M$38.37M$36.97M$36.38M-------
Fertility benefit services revenue$169.77M$171.30M$175.11M$172.74M$157.15M$129.30M$126.79M$110.92M$89.18M$85.31M$92.27M-------
Fertility Benefit Services-----------$88.85M$74.71M$73.14M$46.27M$59.43M$53.53M$50.02M
Pharmacy Benefit Services-----------$33.28M$25.59M$25.79M$18.33M$21.59M$11.59M$11.17M

Progyny's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Fertility benefit services revenue (61.05%), and Pharmacy benefit services revenue (38.95%).

Progyny Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TDOCTeladoc Health$2.60B$640.51M
VEEVVeeva Systems$2.36B$676.18M
EVHEvolent Health$1.96B$647.14M
PRVAPrivia Health Group$1.66B$422.33M
PGNYProgyny$1.09B$304.09M
GDRXGoodRx$750.26M$200.61M
TXG10x Genomics$618.73M$151.65M
PHRPhreesia$356.30M$102.11M
CERTCertara$354.34M$93.31M
HCATHealth Catalyst$295.94M$74.72M
HSTMHealthStream$279.06M$73.09M
DHDefinitive Healthcare$251.41M$63.70M
NRCNational Research$148.58M$35.31M
SLPSimulations Plus$70.01M$18.54M

PGNY Revenue FAQ


Progyny's yearly revenue for 2023 was $1.09B, representing an increase of 38.34% compared to 2022. The company's yearly revenue for 2022 was $786.91M, representing an increase of 57.19% compared to 2021. PGNY's yearly revenue for 2021 was $500.62M, representing an increase of 45.17% compared to 2020.

Progyny's quarterly revenue for Q2 2024 was $304.09M, a 9.35% increase from the previous quarter (Q1 2024), and a 8.85% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $278.08M, a 3.01% increase from the previous quarter (Q4 2023), and a 7.62% increase year-over-year (Q1 2023). PGNY's quarterly revenue for Q4 2023 was $269.94M, a -3.90% decrease from the previous quarter (Q3 2023), and a 25.95% increase year-over-year (Q4 2022).

Progyny's revenue growth rate for the last 3 years (2021-2023) was 117.45%, and for the last 5 years (2019-2023) was 373.96%.

Progyny's revenue streams in c 23 are Fertility benefit services revenue, and Pharmacy benefit services revenue. Fertility benefit services revenue generated $676.3M in revenue, accounting 62.13% of the company's total revenue, up 32.57% year-over-year. Pharmacy benefit services revenue generated $412.3M in revenue, accounting 37.87% of the company's total revenue, up 48.97% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Progyny was Fertility benefit services revenue. This segment made a revenue of $676.3M, representing 62.13% of the company's total revenue.